Pharmaceutical formulation
    2.
    发明授权
    Pharmaceutical formulation 失效
    药物制剂

    公开(公告)号:US5849704A

    公开(公告)日:1998-12-15

    申请号:US458386

    申请日:1995-06-02

    CPC分类号: A61K38/27 C07K14/61

    摘要: A pharmaceutical preparation comprising a growth hormone and histidine or a derivative of histidine as additive or buffering substance shows a very high stability against deamidation, oxidation and cleavage of peptide bonds. The stability of the product allows for the storing and shipment thereof in a lyophilized state or in the form of a dissolved or re-dissolved preparation at ambient temperature. Crystallization of growth hormone in the presence of histidine or a derivative thereof gives rise to a higher yield of crystals having a higher purity than known methods.

    摘要翻译: 包含生长激素和组氨酸或组氨酸衍生物作为添加剂或缓冲物质的药物制剂显示出非常高的抗肽脱离,氧化和切割的稳定性。 产品的稳定性允许在室温下以冻干状态或以溶解或再溶解制剂的形式储存和运输。 在组氨酸或其衍生物存在下生长激素的结晶产生比已知方法具有更高纯度的晶体的较高产率。

    Composition and method comprising growth hormone and leucine
    6.
    发明授权
    Composition and method comprising growth hormone and leucine 失效
    包含生长激素和亮氨酸的组合物和方法

    公开(公告)号:US5654278A

    公开(公告)日:1997-08-05

    申请号:US455886

    申请日:1995-05-31

    CPC分类号: A61K38/27

    摘要: A pharmaceutical formulation comprising a growth hormone and leucine shows a very high stability against deamidation, oxidation and cleavage of peptide bonds. The stability of the product allows for the storing and shipment thereof in a lyophilized state or in the form of a dissolved or re-dissolved formulation at ambient temperature.

    摘要翻译: 包含生长激素和亮氨酸的药物制剂显示出非常高的抗磷酸化,氧化和肽键切割的稳定性。 产品的稳定性允许在室温下以冻干状态或以溶解或再溶解制剂的形式储存和运输。